StockClub

CHRS

CHRSCoherus Oncology, Inc.$ --
Coherus Oncology, Inc.

Coherus Oncology, Inc.

CHRS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
12M USD
YoY +62.0%
Operating Income
-36M USD
YoY +20.4%
Net Income
-38M USD
YoY +32.9%
EPS
-0.28$
YoY +42.9%

Revenue

$12.3M
FY2024 Q2$67.3M
$67.3M
Q2
FY2024 Q3$138.1M
$138.1M
Q3
FY2024 Q4$192.2M
$192.2M
Q4
FY2025 Q1$7.6M
$7.6M
Q1
FY2025 Q2$17.9M
$17.9M
Q2
FY2025 Q3$29.4M
$29.4M
Q3
FY2025 Q4$42.2M
$42.2M
Q4
FY2026 Q1$12.3M
$12.3M
Q1
Actual
+$4.7M (+62.0%)

Net Income

$-37.9M
FY2024 Q2$90M
$90M
Q2
FY2024 Q3$79.2M
$79.2M
Q3
FY2024 Q4$28.5M
$28.5M
Q4
FY2025 Q1$-56.6M
$-56.6M
Q1
FY2025 Q2$-97.9M
$-97.9M
Q2
FY2025 Q3$-133M
$-133M
Q3
FY2025 Q4$-170.3M
$-170.3M
Q4
FY2026 Q1$-37.9M
$-37.9M
Q1
Actual
+$18.6M (+32.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$475.8M
Est:$480.3M
FY2020MISS
$475.8M
FY2021MISS
Actual:$326.6M
Est:$335.7M
FY2021MISS
$326.6M
FY2022MISS
Actual:$211M
Est:$213.3M
FY2022MISS
$211M
FY2023MISS
Actual:$257.2M
Est:$308.1M
FY2023MISS
$257.2M
FY2024BEAT
Actual:$267M
Est:$256.4M
FY2024BEAT
$267M
FY2025MISS
Actual:$42.2M
Est:$43.5M
FY2025MISS
$42.2M

Analyst Estimates